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Abstract: Tetrahydropyran rings are a common feature of
complex polyketide natural products, but much remains to be
learned about the enzymology of their formation. The enzyme
SalBIII from the salinomycin biosynthetic pathway resembles
other polyether epoxide hydrolases/cyclases of the MonB
family, but SalBIII plays no role in the conventional cascade of
ring opening/closing. Mutation in the salBIII gene gave
a metabolite in which ring A is not formed. Using this
metabolite in vitro as a substrate analogue, SalBIII has been
shown to form pyran ring A. We have determined the X-ray
crystal structure of SalBIII, and structure-guided mutagenesis
of putative active-site residues has identified Asp38 and
Asp104 as an essential catalytic dyad. The demonstrated
pyran synthase activity of SalBIII further extends the impres-
sive catalytic versatility of a+ b barrel fold proteins.
Tetrahydropyran rings are widespread features of complex
reduced polyketide natural products, including compounds of
outstanding potential or utility as agrochemicals or pharma-
ceuticals, such as the coccidiostat and anticancer ionophore
salinomycin[1] (Figure 1). Such compounds are formed on
bacterial modular type I polyketide synthases (PKSs), giant
multimodular enzymes that use a remarkable assembly-line
logic for biosynthesis of diverse bioactive natural products.[2]
Each module catalyzes a specific cycle of polyketide chain
elongation, and contains a ketosynthase (KS) domain that
condenses activated acyl and malonyl units, an acyltransferase
(AT) that specifies the type of extender unit introduced, and
an acyl carrier protein (ACP) that tethers the growing
polyketide chain while it is processed by optional ketoreduc-
tase (KR), dehydratase (DH), and enoylreductase (ER)
domains.[3] Some assembly-line PKSs (trans-AT PKSs) lack
module-specific AT domains and show considerable variation
in their domain order compared to cis-AT PKSs.[4] PKSs use
further enzymes to introduce additional chemical diversi-
ty[2a,5] and there is great interest in identifying and character-
izing these auxiliary enzymes.
In polyether ionophores, tetrahydrofuran and tetrahydro-
pyran rings are formed by flavin-linked oxidation of diene- or
triene-containing intermediates to epoxides,[6] and their sub-
sequent ring-opening catalyzed by epoxide hydrolases/
cyclases of the MonB family.[7] However, gene cluster analysis
has suggested that other pyran rings are formed by other
routes.[8] In trans-AT PKS systems, such as the one that
produces pederin (Figure 1), it has been shown that certain
modules contain a DH-like pyran synthase (PS) domain that
acts on the a,b-unsaturated thioester product of the adjacent
DH domain to produce the pyran, before the polyketide chain
is passed to the downstreammodule.[8c,d,e,f] PS domains are not
found in cis-AT PKSs, but recent work on the DH domain of
module 3 of the PKS for ambruticin (Figure 1) showed that
this domain has dual activity, first dehydrating and then
catalyzing stereoselective ring formation.[8g] Sequence com-
parisons reveal no clear differences between AmbDH3 and
monofunctional DH domains from either cis- or trans-AT
PKSs, so the basis of the dual activity is unknown. The cis-AT
PKS for indanomycin (Figure 1) contains an integral domain
(Cyc11) which has been proposed[8h] from gene cluster
Figure 1. Structures of selected polyketides containing pyran rings
(highlighted in gray).
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analysis to form the pyran at the western end of the molecule.
However, experimental evidence for this is lacking.
The salinomycin biosynthetic gene cluster[9] encodes a cis-
AT PKS predicted to give rise to an enzyme-bound diene that
is oxidized by epoxidase SalC to a diepoxide. This in turn is
ring-opened by tandem action of SalBI and SalBII, from the
MonB-family of epoxide hydrolases/cyclases. The sal PKS
shows several unusual features, including a cis-double bond at
C18¢C19 inserted by the novel dehydratase[9c,d] (and putative
spirocyclase[9d]) SalE, and the lack of a conventional off-
loading enzyme.[9] Notably, the final extension module of the
PKS contains neither a DH domain nor a pederin-like PS
domain, so the origin of the pyran ring at the western end of
the molecule has been obscure. The gene salBIII[9a] encodes
a third member of the MonB-family of epoxide hydrolases/
cyclases (Supporting Information, Figure S10), and we wished
to test the hypothesis that this enzyme catalyzes pyran
formation. Previous analysis of a mutant deleted in the salE
dehydratase gene has shown that the metabolites 5, 6, and 7
that accumulate (Supporting Information, Figure S15) all
have pyran ring A present,[9c,d] as does diene 3 (Figure 2),
from a mutant lacking the epoxidase SalC.[9a] These results
imply that pyran formation is an early post-PKS event.
First, we fully confirmed the configuration of metabolite 3
isolated from the DsalC mutant (Supporting Information,
Figure S29) by using 1D- and 2D-NMR analysis (Supporting
Information, Table S1, Figures S1–S9,S33–S46). Next, we
deleted the salBIII gene in Streptomyces albus. LC-MS
analysis of extracts from the DsalBIII mutant strain showed
that salinomycin (m/z 773.5) production was abolished (Fig-
ure S17). Instead, two metabolites with m/z 791.5 were
observed at retention times 8.6 and 11.1 min, respectively.
Production of salinomycin was fully restored in the S. albus
DsalBIII mutant when complemented in trans with the wild-
type salBIII gene. Their MS–MS fragmentation pattern
suggests that these metabolites represent bis-epoxide shunt
products in which pyran ring A is not yet formed (Figur-
es S18,S19). To further clarify the role of SalBIII in pyran
formation, we constructed a double mutant lacking both
salBIII and the epoxidase salC. LC-MS analysis of extracts
from the DsalC/DsalBIII mutant strain showed loss of 3 and
the appearance of small amounts of a new metabolite 2 with
m/z 761.5 (Figure 2; Supporting Information, Figure S21).
Complementation in trans with a wild-type copy of SalBIII
restored the production of 3 (Figure S21). Gene cluster
analysis[9a,c] was used to deduce the stereochemistry of 2,
and the chemical structure was experimentally confirmed by
MS–MS analysis (Figures S22–S28). Comparison of 2 and 3
(Figure 2) strongly implicated SalBIII in converting a PKS-
bound form of 2, tethered in thioester linkage to an ACP
domain, into a PKS-bound form of 3. This could conceivably
occur either by direct SN2-type displacement, or by acting first
as a dehydratase to form an a,b-unsaturated thioester, and
then as a cyclase catalyzing oxa-conjugate addition.
To confirm the activity of SalBIII, we reconstituted pyran
formation in vitro using recombinant SalBIII enzyme purified
from Escherichia coli (Figure S30) with 2 as a surrogate for
the natural ACP-tethered substrate. Metabolite 2 was indeed
slowly converted into 3 by purified SalBIII (Figure 2;
Supporting Information, Figure S31). The identity of the
product of the in vitro reaction was confirmed by showing
that the MS–MS spectrum was identical to that of authentic 3
(Figure S32). The assumed a,b-unsaturated acid intermediate
of the dehydration–addition pathway was not detected, so if
this mechanism is followed then either pyran ring formation
outpaces dehydration or the two reactions are tightly coupled
without release of the intermediate.
To provide a structural framework for understanding the
activity of SalBIII, we have solved the X-ray crystal structure
of SalBIII at 1.8 è resolution. The statistics for data
collection, refinement, and validation are presented in the
Supporting Information (Table S10). Phases were determined
by molecular replacement. There are two protomers in the
asymmetric unit, consistent with the fact that SalBIII is
a homodimer in solution (Figure S30). Each subunit adopts
the cone-shaped a+ b barrel fold[10] first recognized in the
structure of scytalone dehydratase[10a] in which three or four
a-helices pack against the concave side of a curved five- or
six-stranded mixed b-pleated sheet, creating a largely hydro-
phobic active site cavity (Figure 3), closed at one end. This
fold has subsequently been observed in diverse enzymes
utilizing general acid–general base catalysis.[10] The most
similar 3D structures to that of SalBIII are those of the
MonB-type epoxide hydrolases,[7] but sequence alignment
(Figure S10) shows that in SalBIII one of the two catalytic
residues (Asp38 and Glu65 in Lsd19/LasB N-terminal
domain) is missing, and overall its sequence diverges signifi-
cantly from other members of this family (Figure S11). Using
the crystal structure of SalBIII as a guide (Figure 3), eight
residues were identified as contributing to its active site:
Tyr14, Asp38, Arg45, Tyr54, Asn58, Ile65, Asp104, and
Trp121. Site-specific mutagenesis was used to mutate these
residues, and the mutant genes were tested for their ability to
Figure 2. In vitro analysis of the reaction catalyzed by recombinant
SalBIII. a) Reaction catalyzed by SalBIII. b) Stacked spectra from
HPLC-MS analysis showing formation of 3 in the presence of SalBIII.
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restore salinomycin production to the S. albus DsalBIII strain.
The results (summarized in Table S9) showed that each of the
Tyr14Phe, Tyr54Phe, Asn58Ala, Ile65Thr, and Arg45Ala
mutants substantially restored salinomycin production,
while only low salinomycin production was seen for the
Trp121Ala mutant. In contrast, alteration of either Asp38 or
Asp104 (to either Ala or Asn) gave wholly inactive mutants.
These residues are suitably placed in the active site to operate
as a catalytic dyad, to accomplish both dehydration and oxa-
conjugate addition. Their positioning on the same side of the
active site pocket appears to rule out a direct displacement
mechanism in which one group acts as a general acid to assist
the departing C3-OH and the other as a general base to assist
the C7-OH nucleophile. The mechanism we propose
(Scheme 1) involves an E1cb-like elimination, in which
general base-catalyzed cleavage of a C¢H bond at C2 to
form a stabilized enolate is followed by b-elimination from
C3.[11] Asp38 is proposed to furnish the general base for
proton abstraction, and the formation and stabilization of the
enolate may also be favored by general acid catalysis
involving polarization of the thioester carbonyl. Asp104 is
proposed to assist b-elimination from C3. The a,b-unsatu-
rated thioester then undergoes oxa-conjugate addition of the
C7 hydroxy group, assisted by Asp104, leading to syn addition
across the double bond. Asp38 may assist ring formation by
hydrogen-bonding to the thioester carbonyl, or may provide
the proton at C2 of the pyran product. Further experiments to
test this mechanistic proposal are in progress.
Sequence alignment of the putative cyclase domain Cyc11
from the indanomycin PKS[8h] with SalBIII (Figure S12)
revealed that Cyc11 contains equivalent residues (Asp28
and Asp94) to those found here to be essential to SalBIII
activity. Superimposition of the modeled active site structure
of Cyc11 and that of Lsd19/LasB C-terminal domain[10e] onto
the active site of SalBIII shows that they occupy exactly
equivalent positions (Figure 3). Also, Arg45, Tyr54, and Ile65
of SalBIII have close counterparts in Cyc11, consistent with
one or more of these residues also playing a catalytic role
(Figure 3). It therefore seems probable that Cyc11 adopts
a similar catalytic mechanism for pyran formation. The
identification of SalBIII as a pyran synthase provides an
additional tool for potential chemoenzymatic synthesis of
pyrans, and further extends the impressive catalytic versatility
shown by proteins and domains adopting the a+ b barrel fold.
Figure 3. Crystal structure of SalBIII. a) Overall fold of SalBIII. The
right-hand monomer is shown with its electrostatic surface (blue:
negatively charged; red: positively charged). PEG: polyethylene glycol.
b) Predicted active site residues in SalBIII. c) Superposition of the
active sites of SalBIII (orange), Cyc11 (model, gray) and Lsd19
(green).
Scheme 1. Proposed mechanism of the intramolecular cyclization
catalyzed by SalBIII. Asp38 and Asp104 constitute a catalytic dyad.
ACP14 : the terminal acyl carrier protein domain of the sal PKS.
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